Brain drug delivery and blood-brain barrier transport

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 3, Issue 2, 1996, Pages 99-115

  Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARMUSTINE; CATION; CHIMERIC PROTEIN; CODEINE; CYCLOSPORIN; CYTARABINE; DIAZEPAM; DOPAMINE; HYDROXYUREA; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE]; LEVODOPA; LIPOSOME; MELPHALAN; MONOCLONAL ANTIBODY; MORPHINE; PEPTIDE DERIVATIVE; PRODRUG; RADIOISOTOPE; SUCROSE; THIOTEPA; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; ZIDOVUDINE;

BLOOD BRAIN BARRIER; BRAIN; DIFFUSION; DRUG ADMINISTRATION; DRUG TRANSPORT; GENE TRANSFER; HUMAN; LIPID SOLUBILITY; LIPOPHILICITY; MEMBRANE TRANSPORT; METHODOLOGY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029786047     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549609031180     Document Type: Review

References (90)

1. Mollgard, K., and Saunders, N. R. (1975) Complex tight junctions of epithelial and of endothelial cells in early foetal brain. J. Neurocytol. 4, 453-468.
2. Duvernoy, H., Delon, S., and Vannson, J. L. (1983) The vascularization of the human cerebellar cortex. Brain Res. Bull. 11, 419-480.
3. Pardridge, W. M. (1991) "Peptide Drug Delivery to the Brain," pp. 1-357, Raven Press, New York.
4. Pardridge, W. M. (1986) Blood-brain nutrient transport. Fed. Proc. 45, 2047-2049.
5. Pardridge, W. M. (1993) Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann. N.Y. Acad. Sci. 692, 126-137.
6. Brightman, M. W. (1977) Morphology of blood-brain interfaces. Exp. Eye Res. 25(Suppl.), 1-25.
7. Butt, A. M., Jones, H. C., and Abbott, N. J. (1990) Electrical resistance across the blood-brain barrier in anaesthetized rats: A developmental study. J. Physiol. 429, 47-62.
8. Pardridge, W. M., Yang, J., Buciak, J., and Tourtellotte, W. W. (1989) Human brain microvascular DR antigen. J. Neurosci. Res. 23, 337-341.
9. Miller, F. N., and Sims, D. E. (1986) Contractile elements in the regulation of macromolecular permeability. Fed. Proc. 45, 84-88.
10. Nehls, V., and Drenckhahn, D. (1991) Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J. Cell Biol. 113, 147-154.
11. Johanson, C. E. (1980) Permeability and vascularity of the developing brain: Cerebellum vs. cerebral cortex. Brain Res. 190, 3-16.
12. Stewart, P. A., and Wiley, M. J. (1981) Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimera. Dev. Biol. 84, 183-192.
13. Janzer, R. C., and Raff, M. C. (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257.
14. Kapadia, S. E., and de Lanerolle, N. C. (1984) Immunohistochemical and electron microscopic demonstration of vascular innervation in the mammalian brainstem. Brain Res. 292, 33-39.
15. Pardridge, W. M., and Boado, R. J. (1993) Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In "The Blood-Brain Barrier: Cellular and Molecular Biology" (W. M. Pardridge, Ed.), pp. 395-440, Raven Press, New York.
16. +) of the rat blood-brain barrier. J. Neurochem. 60, 1956-1959.
17. Duffy, K. R., and Pardridge, W. M. (1987) Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 420, 32-38.
18. Pardridge, W. M., Eisenberg, J., and Yang, J. (1985) Human blood-brain barrier insulin receptor. J. Neurochem. 44, 1771-1778.
19. Jeffries, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., and Mason, D. Y. (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312, 162-163.
20. Pardridge, W. M., Eisenberg, J., and Yang, J. (1987) Human blood-brain barrier transferrin receptor. Metabolism 36, 892-895.
21. Fishman, J. B., Ruben, J. B., Handrahan, J. V., Connor, J. R., and Fine, R. E. (1987) Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J. Neurosci. Res. 18, 299-304.
22. Roberts, R. L., Fine, R. E., and Sandra, A. (1993) Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J. Cell Sci. 104, 521-532.
23. Morris, C. M., Keith, A. B., Edwardson, J. A., and Pullen, R. G. L. (1992) Uptake and distribution of iron and transferrin in the adult rat brain. J. Neurochem. 59, 300-306.
24. 125I]transferrin through the rat blood-brain barrier in vivo. Brain Res. 683, 164-171.
25. Casella, S. J., Han, V. K., D'Ercole, A. J., et al. (1986) Insulin-like growth factor II binding to the type I somatomedin receptor: Evidence for two high affinity binding sites. J. Biol. Chem. 261, 9268-9272.
26. Banks, W. A., Ortiz, L., Plotkin, S. R., and Kastin, A. J. (1991) Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259, 988-996.
27. Voyta, J. C., Via, D. P., Butterfield, C. E., and Zetter, B. R. (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99, 2034-2040.
28. Triguero, D., Buciak, J. B., and Pardridge, W. M. (1990) Capillary depletion method for quantifying blood-brain barrier transcytosis of circulating peptides and plasma proteins. J. Neurochem. 54, 1882-1888.
29. Broadwell, R. D., Balin, B. J., and Salcman, M. (1988) Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc. Natl. Acad. Sci. USA 85, 632-636.
30. Fishman, R. A. (1980) "Cerebrospinal Fluid in Diseases of the Nervous System," Saunders, Philadelphia.
31. Blasberg, R. G., Patlak, C., and Fenstermacher, J. D. (1975) Intrathecal chemotherapy: Brain tissue profiles after ventriculocisternal perfusion. J. Pharmacol. Exp. Ther. 195, 73-83.
32. Ferguson, I. A., Schweitzer, J. B., Barlett, P. F., and Johnson, E. M., Jr. (1991) Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors. J. Comp. Neurol. 313, 680-692.
33. Billiau, A., Heremans, H., Ververken, D., van Damme, J., Carton, H., and de Somer, P. (1981) Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice. Arch. Virol. 68, 19-25.
34. Collins, J. M., Riccardi, R., Trown, P., O'Neill, D., and Poplack, D. G. (1985) Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: Comparison of intravenous, intramuscular, and intraventricular delivery. Cancer Drug Del. 2, 247-253.
35. Greig, N. H., Fredericks, W. R., Holloway, H. W., Soncrant, T. T., and Rapoport, S. I. (1988) Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat. J. Pharmacol. Exp. Ther. 245, 581-586.
36. Covell, D. G., Narang, P. K., and Poplack, D. G. (1985) Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. Am. J. Physiol. 248, R147-R156.
37. Neuwelt, E. A., and Rapoport, S. I. (1984) Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed. Proc. 43, 214-219.
38. Salahuddin, T. S., Kalimo, H., Johansson, B. B., and Olsson, Y. (1988) Observations on exsudation of fibronectin, fibrinogen, and albumin in the brain after carotid infusion of hyperosmolar solutions. Acta Neuropathol. 76, 1-10.
39. 4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J. Cerebral Blood Flow Metab. 11, 638-643.
40. Gennuso, R., Spigelman, M. K., Chinol, M., Zappulla, R. A., Nieves, J., Vallabhajosula, S., Paciucci, P. A., Goldsmith, S. T., and Holland, J. F. (1993) Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake. Cancer Invest. 11, 118-128.
41. Cornford, E. M., Young, D., Paxton, J. W., Finlay, G. J., Wilson, W. R., and Pardridge, W. M. (1992) Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain. Cancer Res. 52, 138-143.
42. Nagy, Z., Szabo, M., and Huttner, I. (1985) Blood-brain barrier impairment by low pH buffer perfusion via the internal carotid artery in rat. Acta Neuropathol. 68, 160-163.
43. Levin, V. A. (1980) Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23, 682-684.
44. Greig, N. H., Soncrant, T. T., Shetty, H. U., Momma, S., Smith, Q. R., and Rapoport, S. I. (1990). Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat. Cancer Chemother. Pharmacol. 26, 263-268.
45. Wenger, R. (1982) Chemistry of cyclosporin. In "Cyclosporin A" (D. J. G. White, Ed.), pp. 19-34, Elsevier Biomedical Press, New York.
46. Gregoriadis, G. (1976) The carrier potential of liposomes in biology and medicine. N. Engl. J. Med. 295, 704-710.
47. Trauble, H. (1971) The movement of molecules across lipid membranes: A molecular theory. J. Membr. Biol. 4, 193-208.
48. Oldendorf, W. H., Hyman, S., Braun, L., and Oldendorf, S. Z. (1972) Blood-brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 178, 984-986.
49. Hostetler, K. Y., Stuhmiller, L. M., Lenting, H. B. M., van den Bosch, H., and Richman, D. D. (1990) Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides. J. Biol. Chem. 265, 6112-6117.
50. Dhopeshwarkar, G. A., Subramanian, C., McConnell, D. H., and Mead, J. F. (1972) Fatty acid transport into the brain. Biochim. Biophys. Acta 255, 572-579.
51. 2]leu-enkephalin derivatives conjugated with 1-adamantane moiety. Biochem. Pharmacol. 41, R5-R8.
52. Bewley, T. A., and Li, C. H. (1983) Evidence for tertiary structure in aqueous solutions of human β-endorphin as shown by difference absorption spectroscopy. Biochemistry 22, 2671-2675.
53. Bodor, N., Prokai, L., Wu, W.-M., Farag, H., Jonalagadda, S., Kawamura, M., and Simpkins, J. (1992) A strategy for delivering peptides into the central nervous system by sequential metabolism. Science 257, 1698-1700.
54. Hanig, J. P., Morrison, J. M., Jr., and Krop, S. (1972) Ethanol enhancement of blood-brain barrier permeability to catecholamines in chicks. Eur. J. Pharmacol. 18, 79-82.
55. Hanig, J. P., Morrison, J. M., Jr., and Krop, S. (1971) Increase of blood-brain barrier permeability to catecholamines by dimethyl sulphoxide in the neonate chick. J. Pharm. Pharmacol. 23, 386-387.
56. Wade, L. A., and Katzman, R. (1975) Synthetic amino acids and the nature of L-dopa transport at the blood-brain barrier. J. Neurochem. 25, 837-842.
57. Greig, N. H., Momma, S., Sweeney, D. J., Smith, Q. R., and Rapoport, S. I. (1987) Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res. 47, 1571-1576.
58. Takada, Y., Vistica, D. T., Greig, N. H., Purdon, D., Rapoport, S. I., and Smith, Q. R. (1992) Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Cancer Res. 52, 2191-2196.
59. Kim, S., Scheerer, S., Geyer, M. A., and Howell, S. B. (1990) Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes. J. Infect. Dis. 162, 750-752.
60. Walker, C., Selby, M., Erickson, A., Cataldo, D., Valensi, J.-P., and Van Nest, G. (1992) Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc. Natl. Acad. Sci. USA 89, 7915-7918.
61. Micklus, M. J., Greig, N. H., Tung, J., and Rapoport, S. I. (1993) Targeting of liposomes to the blood-brain barrier in rats. Drug Del. 1, 21-26.
62. Triguero, D., Buciak, J. B., Yang, J., and Pardridge, W. M. (1989) Blood-brain barrier transport of cationized immunoglobulin G: Enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. USA 86, 4761-4765.
63. Vorbrodt, A. W. (1989) Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J. Neurocytol. 18, 359-368.
64. Hata, A., Ridinger, D. N., Sutherland, S., Emi, M., Shuhua, Z., Myers, R. L., Ren, K., Cheng, T., Inoue, I., Wilson, D. E., Iverius, P.-H., and Lalouel, J.-M. (1993) Binding of lipoprotein lipase to heparin. J. Biol. Chem. 268, 8447-8457.
65. Pardridge, W. M, Kang, Y.-S., Yang, J., and Buciak, J. L. (1995) Enhanced cellular uptake and in vivo biodistribution of an anti-ras monoclonal antibody following cationization. J. Pharm. Sci. 84, 943-948.
66. 68Ga]EDTA and positron emission tomography. J. Cereb. Blood Flow Metab. 7, 1-8.
67. Bickel, U., Lee, V. M. Y., Trojanowski, J. Q., and Pardridge, W. M. (1994) Development and in vitro characterization of a cationized monoclonal antibody against βA4 protein: A potential probe for Alzheimer's disease. Bioconj. Chem. 5, 119-125.
68. Wisniewski, H., Johnson, A. B., Raine, C. S., Kay, W. J., and Terry, R. D. (1970) Senile plaques and cerebral amyloidosis in aged dogs: A histochemical and ultrastructural study. Lab. Invest. 23, 287-296.
69. Stern, R. A., Otvos, L., Jr., Trojanowski, J. Q., and Lee, V. M.-Y. (1989) Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease β-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am. J. Pathol. 134, 973-978.
70. Pardridge, W. M. (1983) Neuropeptides and the blood-brain barrier. Ann. Rev. Physiol. 45, 73-82.
71. Banks, W. A., and Kastin, A. J. (1990) Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259, E1-E10.
72. Banks, W. A., Kastin, A. J., and Barrera, C. M. (1991) Delivering peptides to the central nervous system: Dilemmas and strategies. Pharm. Res. 8, 1345-1350.
73. Bickel, U., Yoshikawa, T., and Pardridge, W. M. (1993) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Del. Rev. 10, 205-245.
74. Samii, A., Bickel, U., Stroth, U., and Pardridge, W. M. (1994) Quantitation of blood-brain barrier transport of neuropeptides with a metabolically stable dermorphin analogue. Am. J. Physiol. 267, E124-E131.
75. Bickel, U., Kang, Y.-S., and Pardridge, W. M. (1995). In vivo cleavage of a disulfide-based chimeric ooioid peptide in rat brain. Bioconj. Chem. 6, 211-218.
76. Pardridge, W. M. (1986) Receptor-mediated peptide transport through the blood-brain barrier. Endocrine Rev. 7, 314-330.
77. Pardridge, W. M., Boado, R. J., and Buciak, J. L. (1993) Drug delivery of antisense oligonucleotides or peptides to tissues in vivo using an avidin-biotin system. Drug Del. 1, 43-50.
78. Friden, P. M., Walus, L., Musso, G. F., Taylor, M. A., Malfroy, B., and Starzyk, R. M. (1991) Antitransferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl. Acad. Sci. USA 88, 4771-4775.
79. Pardridge, W. M., Buciak, J. L., and Friden, P. M. (1991) Selective transport of anti-transferrin receptor antibody through the blood-brain barrier in vivo. J. Pharmacol. Exp. Ther. 259, 66-70.
80. Yoshikawa, T., and Pardridge, W. M. (1992) Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. J. Pharmacol. Exp. Ther. 263, 897-903.
81. Kang, Y.-S., and Pardridge, W. M. (1994) Use of neutral-avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. J. Pharmacol. Exp. Ther. 269, 344-350.
82. Bickel, U., Yoshikawa, T., Landaw, E. M., Faull, K. F., and Pardridge, W. M. (1993) Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. USA 90, 2618-2622.
83. Andersson, M., Marie, J.-C., Carlquist, M., and Mutt, V. (1991) The preparation of biotinyl-∈-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor. FEBS Lett. 282, 35-40.
84. O'Donnell, M., Garippa, R. J., O'Neill, N. C., Bolin, D. R., and Cottrell, S. M. (1991) Structure-activity studies of vasoactive intestinal polypeptide. J. Biol. Chem. 266, 6389-6392.
85. Berntman, L., Carlsson, C., Hagerdal, M., and Siesjo, B. K. (1976) Excessive increase in oxygen uptake and blood flow in the brain during amphetamine intoxication. Acta Physiol. Scand. 97, 264-266.
86. Huffman, L., and Hedge, G. A. (1986) Effects of vasoactive intestinal peptide on thyroid blood flow and circulating thyroid hormone levels in the rat. Endocrinology 118, 550-557.
87. Itakura, T., Okuno, T., Nakakita, K., Kamei, I., Naka, Y., Nakai, K., Imai, H., Komai, N., Kimura, H., and Maeda, T. (1984) A light and electron microscopic immunohistochemical study of vasoactive intestinal polypeptide - and substance p - containing nerve fibers along the cerebral blood vessels: Comparison with aminergic and cholinergic nerve fibers. J. Cerebral Blood Flow Metab. 4, 407-414.
88. Yaksh, T. L., Wang, J.-Y., Go, V. L. W., and Harty, G. J. (1987) Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by physiological stimuli in the cat. J. Cerebral Blood Flow Metab. 7, 315-326.
89. Pardridge, W. M., Kang, Y.-S., and Buciak, J. L. (1994) Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11, 738-746.
90. Abuchowski, A., van Es, T., Palczuk, N. C., and Davis, F. F. (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252, 3578-3581.